IT0003492391
IT0003492391
DIASORIN
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 3.81B EUR | 3.35B EUR | 3.02B EUR |
Enterprise Value | 4.67B EUR | 4.19B EUR | 3.02B EUR |
Valuation Multiples | |||
Trailing P/E | 28.46x | 70.76x | 30.37x |
Forward P/E | 17.85x | -- | -- |
Price to Sales | 3.24x | 10.95x | 4.87x |
Price to Book | 2.69x | 2.36x | -- |
EV/Revenue | 3.97x | 13.69x | 4.87x |
EV/EBITDA | 13.66x | 53.53x | 19.69x |
Price to FCF (P/FCF) | 28.74x | 309.5x | 36.89x |
EV/FCF | 35.18x | 386.89x | 36.89x |
FCF Yield | 3.48% | 0.32% | 2.71% |